Skip to main content
Clinical Trials/EUCTR2008-005237-30-SE
EUCTR2008-005237-30-SE
Active, not recruiting
Not Applicable

A Multicenter, Prospective, Long-term Registry of Pediatric Patients with Crohn's Disease - DEVELOP

Janssen Biologics BV0 sites4,000 target enrollmentAugust 16, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pediatric patients with a confirmed diagnosis of CD aged 6 years to lessthan 17 years of age at the time of enrollment
Sponsor
Janssen Biologics BV
Enrollment
4000
Status
Active, not recruiting
Last Updated
13 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 16, 2011
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Have a confirmed diagnosis of CD for at least 2 months.
  • 2\. Are male or female at least 6 years of age, but less than 17 years of
  • 3\. The parent/legal guardian must be capable of providing written
  • informed consent, and assent should be obtained from the child according to local regulations (age at which assent is given may vary by the IRB or EC).
  • 4\. The patient's physician expects the patient to be scheduled for a
  • medical encounter (and/or other direct contact) at least every 6 months, as part of their usual care, at the time of enrollment.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range

Exclusion Criteria

  • Patients meeting any of the following criteria may not be enrolled in the
  • 1\. Are less than 6 years of age or 17 years of age or older.
  • 2\. The patient and parent/guardian are not able to adhere to the
  • protocol requirements.
  • 3\. Have other Crohn's\-like diseases that are associated with genetic
  • diseases (eg, glycogen storage disease).
  • 4\. Are participating in any clinical trial for an investigational agent that
  • is not commercially available.
  • 5\. Are currently participating in a Centocor\-sponsored trial for pediatric
  • CD (eg, RESULTS \[C0168T45]).

Outcomes

Primary Outcomes

Not specified

Similar Trials